1. Home
  2. STXS vs MSLE Comparison

STXS vs MSLE Comparison

Compare STXS & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.36

Market Cap

164.1M

Sector

Health Care

ML Signal

N/A

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$9.26

Market Cap

154.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STXS
MSLE
Founded
1990
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.1M
154.6M
IPO Year
2004
2007

Fundamental Metrics

Financial Performance
Metric
STXS
MSLE
Price
$1.36
$9.26
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
590.0K
18.5K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
16.67
N/A
EPS
N/A
N/A
Revenue
$29,346,617.00
N/A
Revenue This Year
$28.22
N/A
Revenue Next Year
$30.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.24
$5.44
52 Week High
$3.59
$13.39

Technical Indicators

Market Signals
Indicator
STXS
MSLE
Relative Strength Index (RSI) 45.90 45.24
Support Level $1.30 $6.71
Resistance Level $1.96 $9.75
Average True Range (ATR) 0.06 0.49
MACD 0.01 -0.16
Stochastic Oscillator 40.05 20.69

Price Performance

Historical Comparison
STXS
MSLE

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: